Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated 1 day ago
Questions and answers for biological medicinal products
1 day ago
Questions and answers for biological medicinal products
Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 4, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Celldemic, zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures), Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Celldemic, zoonotic influenza vaccine (H5N1)...
Human medicines European public assessment report (EPAR): Incellipan, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures), Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Incellipan, pandemic influenza vaccine (H5N1)...
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Suboxone, buprenorphine,naloxone, Date of authorisation: 26/09/2006, Revision: 24, Status: Withdrawn
1 day ago
Human medicines European public assessment report (EPAR): Suboxone, buprenorphine,naloxone, Date of authorisation...
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Revision: 2...
Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 22, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation...
Suboxone : EPAR - Procedural steps taken before authorisation
2 days ago
Suboxone : EPAR - Procedural steps taken before authorisation